Analyst Ranking
Bottom 2%
#4873 out of 4929 analysts
Average Return
-10.5%
Win Rate
36%53 out of 148
Risk vs Reward
Poor
Good

Andrew Berens's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Forma Therapeutics Holdings IncFMTX
+246.79%$5.77$20.01
2022-05-27 -
2022-10-13
Buy
Turning Point Therapeutics IncTPTX
+191.29%$25.50$74.28
2022-05-11 -
2022-06-13
Buy
Global Blood Therapeutics IncGBT
+167.43%$24.90$66.59
2021-12-14 -
2022-08-09
Buy
Blueprint Medicines CorpBPMC
+130.14%$35.87$82.55
2017-02-15 -
2018-02-15
Strong Buy
Global Blood Therapeutics IncGBT
+113.84%$31.14$66.59
2021-12-21 -
2022-08-09
Buy

Andrew Berens Analyst Color

Get additional color on Andrew Berens's coverage of popular stocks

Andrew Berens's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Nuvalent IncNUVL
2Buy$140.00+73.96%Maintains
13 days ago
Arvinas IncARVN
6Hold$9.00+13.21%Downgrades
a month ago
Compass Therapeutics IncCMPX
3Buy$6.00+115.83%Upgrades
3 months ago
Elevation Oncology IncELEV
5Hold$1.00+157.73%Downgrades
4 months ago
Onkure Therapeutics IncOKUR
1Buy$33.00+1,286.55%Initiates Coverage On
7 months ago
Zymeworks IncZYME
10Buy$25.00+91.72%Upgrades
8 months ago
Gilead Sciences IncGILD
1Buy$96.00-14.09%Upgrades
9 months ago
Agios Pharmaceuticals IncAGIO
9Hold$56.00+55.25%Downgrades
9 months ago
Viracta Therapeutics IncVIRX
5Hold$3.00+3,746.15%Downgrades
a year ago
Celcuity IncCELC
1Buy$29.00+110.30%Initiates Coverage On
a year ago
Blueprint Medicines CorpBPMC
17Hold$97.00N/AUpgrades
a year ago
Incyte CorpINCY
12Buy$78.00N/AUpgrades
2 years ago
Mirati Therapeutics IncMRTX
7Hold$58.00N/ADowngrades
2 years ago
Cti Biopharma CorpCTIC
2Hold$9.10N/ADowngrades
2 years ago
Merus NvMRUS
5Buy$48.00N/AMaintains
2 years ago
Deciphera Pharmaceuticals IncDCPH
8Buy$30.00N/AReiterates
2 years ago
Seagen IncSGEN
19Hold$141.00N/ADowngrades
2 years ago
Beone Medicines LtdONC
9Buy$300.00N/AMaintains
2 years ago
Cogent Biosciences IncCOGT
4Buy$20.00N/AMaintains
3 years ago
Nurix Therapeutics IncNRIX
3Buy$28.00N/AMaintains
3 years ago
Astrazeneca PLCAZN
10Buy$79.00N/AMaintains
3 years ago
Zentalis Pharmaceuticals IncZNTL
7Buy$27.00N/AMaintains
3 years ago
Aveo Pharmaceuticals IncAVEO
3HoldN/AN/ADowngrades
3 years ago
Hookipa Pharma IncHOOK
4Buy$30.00N/AMaintains
3 years ago
Global Blood Therapeutics IncGBT
4Hold$68.50N/ADowngrades
3 years ago
Turning Point Therapeutics IncTPTX
5Hold$76.00N/ADowngrades
3 years ago
Forma Therapeutics Holdings IncFMTX
5Buy$23.00N/AMaintains
3 years ago
Cullinan Therapeutics IncCGEM
3Buy$25.00N/AMaintains
3 years ago
Aura Biosciences IncAURA
1Buy$40.00N/AInitiates Coverage On
4 years ago
Theseus Pharmaceuticals IncTHRX
1Buy$28.00N/AInitiates Coverage On
4 years ago
C4 Therapeutics IncCCCC
1Buy$67.00N/AInitiates Coverage On
4 years ago
Monte Rosa Therapeutics IncGLUE
1Hold$20.00N/AInitiates Coverage On
4 years ago
Tango Therapeutics IncTNGX
1Buy$25.00N/AInitiates Coverage On
4 years ago
Epizyme IncEPZM
4Buy$16.00N/AUpgrades
4 years ago
Clovis Oncology IncCLVSQ
2Sell$5.00N/ADowngrades
5 years ago
Nabriva Therapeutics PLCNBRVF
2Strong Buy$2,000.00N/AReinstates
7 years ago
Tesaro IncTSRO
2Strong Buy$146.00N/AMaintains
7 years ago
Intercept Pharmaceuticals IncICPT
1Strong Sell$50.00N/AMaintains
8 years ago
Ocular Therapeutix IncOCUL
2Hold$8.00N/AMaintains
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.